Suvretta Capital Management’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $8.93M | Buy |
|
|||||
|
2024
Q2 | $4.47M | Sell |
|
|||||
|
2024
Q1 | $46.2M | Sell |
|
|||||
|
2023
Q4 | $58.1M | Buy |
|
|||||
|
2023
Q3 | $41.9M | Buy |
|
|||||
|
2023
Q2 | $44.1M | Sell |
|
|||||
|
2023
Q1 | $33.3M | Buy |
|
|||||
|
2022
Q4 | $19.2M | Buy |
|
|||||
|
2022
Q3 | $23.5M | Buy |
|
|||||
|
2022
Q2 | $17M | Buy |
|
|||||
|
2022
Q1 | $25.9M | Buy |
|
|||||
|
2021
Q4 | $31.3M | Buy |
|
|||||
|
2021
Q3 | $25M | Buy |
|
|||||
|
2021
Q2 | $32.8M | Hold |
|
|||||
|
2021
Q1 | $28.3M | Buy |
|
|||||
|
2020
Q4 | $17.4M | Buy |
|
|||||
|
2020
Q3 | $10M | Buy |
|
|||||
|
2020
Q2 | $5.08M | Buy |
|